Loading...
NPI 1497496756 · Downers Grove, IL · Clinical Medical Laboratory
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Hallman Care LLC is a clinical medical laboratory provider located in Downers Grove, Illinois. This profile covers 3 Medicare and 1 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Organization |
| Organization | Hallman Care LLC |
| Address | 1213 Butterfield Rd Fl 2 |
| City | Downers Grove |
| State | IL |
| ZIP | 60515 |
| Taxonomy | Clinical Medical Laboratory |
| NPI Enumerated | April 1, 2022 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicare | $16.8M |
| Medicaid | $3.4K |
HALLMAN CARE LLC is listed as a Clinical Medical Laboratory with its NPI enumerated 2022-04-01 (~4 years ago). Its Medicare billing profile is dominated by the COVID-19 self-test provision code K1034, which the claims listing shows at $17.1M revenue and labeled as 100.0% of this provider's total Medicare revenue, indicating a highly specialized service mix.
Revenue concentration is extreme across both payers: the precomputed top-3 Medicare codes account for 100.0% of Medicare revenue, and the top-3 Medicaid codes account for 100.0% of Medicaid revenue. This indicates virtually no revenue diversification outside the listed CPT/HCPCS codes.
Payer mix is heavily Medicare-skewed in scale: Total Medicare revenue is $16.8M versus Total Medicaid revenue of $3.4K, so Medicare represents the overwhelming share of this provider’s reported public-payer business. In practice the entity functions as effectively single-payer dominated by Medicare flows.
K1034’s competitive standing on Medicare is nationally pronounced: it is ranked #25 of 30143 providers nationally (100th percentile; extreme outlier, far above typical national volume for this code), which identifies HALLMAN CARE LLC as an outlier operator for that service. By contrast, the related molecular test codes U0003 and U0005 show only 86 claims each with $6.4K and $2.2K revenue respectively, are recorded as 0.0% of this provider’s Medicare revenue, and rank in mid percentiles (U0003: #483 of 973, U0005: #573 of 1090), indicating typical, unremarkable volumes for those specific PCR-style services.
Medicaid activity is minimal and fully concentrated in K1034: the Medicaid listing shows K1034 with 1.8K claims at $2 avg paid/claim for $3.6K revenue and is reported as 100.0% of this provider’s total Medicaid revenue; it ranks #17 of 59 in-state (72th percentile; typical, unremarkable volume). Given the $3.4K total Medicaid revenue, the provider is not a major Medicaid participant despite offering the same self-test product to that payer.
Service-line implications from the code mix point to an operation focused on provision/distribution of nonprescription self-administered COVID-19 tests rather than a broad clinical laboratory testing menu. The presence of K1034 as the dominant revenue source, with only small, typical volumes of nucleic-acid detection codes (U0003/U0005), suggests billing emphasis on retail/at-home test provisioning and limited high-complexity PCR testing throughput.
The statistical labels emphasize the unusual Medicare footprint: K1034 is characterized as an "extreme outlier, far above typical national volume for this code," underscoring that HALLMAN CARE LLC’s national prominence for that code is exceptional. Operational or reimbursement changes affecting K1034 would therefore disproportionately affect the provider’s Medicare revenue given the concentration.
Given the NPI was enumerated 2022-04-01 (~4 years ago) and the provider already appears as a national outlier for K1034 on Medicare, this profile suggests rapid scaling or a narrowly specialized business model since enrollment. Analysts assessing competitive standing or reimbursement risk should prioritize monitoring K1034 volume trends and related payer policy changes.
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
3 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| K1034 | Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count | 1,424,620 | $10 | $17.1M |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high… | 90 | $70 | $6.4K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc,… | 90 | $30 | $2.1K |
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 3 CPT/HCPCS codes.
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
1 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| K1034 | Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count | 1,810 | $1 | $3.6K |
How this provider's Medicaid billing volume and revenue compare to other Illinois providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Illinois median
1 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| K1034 | Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count | 17 | 60 | 660 | $1 | $3.2K |
Other providers in the same ZIP code as Hallman Care LLC, ranked by combined Medicare and Medicaid revenue.
| Provider | State | Taxonomy | Medicare Revenue | Medicaid Revenue |
|---|---|---|---|---|
| Byram Healthcare Centers, Inc. | IL | Durable Medical Equipment & Medical Supplies | $0 | $142.4M |
| Village Of Downers Grove | IL | Land Ambulance | $518.8K | $9.5M |
| Lifeline Biosciences LLC | IL | Clinical Medical Laboratory | $1.7M | $7.3M |
| Dupage County Diagnostics LLC | IL | Clinical Medical Laboratory | $0 | $6.8M |
| Advocate Home Care Products Inc | IL | Home Infusion Therapy Pharmacy | $0 | $5.4M |
| Augustus Labs LLC | IL | Clinical Medical Laboratory | $475.4K | $3.7M |
| Cynthia Wollenschlager | IL | Infectious Disease Physician | $47.7K | $1.5M |
| Midwest Center For Day Surgery, LLC | IL | Ambulatory Surgical Clinic/Center | $1.4M | $70 |
| Prashanth Tamragouri | IL | Psychiatry Physician | $420.2K | $602.8K |
| Apex Quality Health | IL | Clinical Medical Laboratory | $932.2K | $12.6K |
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.